Crédit Agricole Alpes Provence's CAAP INNOV'ECO endowment fund open to Eurobiomed members

June 2, 2025

As a mutual and regional bank, Crédit Agricole Alpes Provence mobilizes its financial and human resources to support the economic development of its region, and in particular, through its partnership with Eurobiomed, that of healthcare innovators. Focus today on the CAAP INNOV'ECO endowment fund.

Because innovation and entrepreneurship are the driving forces, Crédit Agricole Alpes Provence's Capital & Innovation division, with its CAAP INNOV'ECO Endowment Fund and its CAAP CREATION innovation capital fund, works on a daily basis to facilitate, finance and highlight the creation and development of innovative businesses in Marseille, Aix-en-Provence, Avignon, Gap,...

Around 15 projects a year

Crédit Agricole Alpes Provence stands out for its commitment to innovation and local entrepreneurship with CAAP INNOV'ECO. Since its creation in 2015, this fund has been endowed each year with 1% of the bank's net income to support innovative projects and support structures in Bouches-du-Rhône, Vaucluse and Hautes-Alpes, offering, among other things, a valuable honor loan to the founders of startups with high technological content. Every year, some fifteen projects are supported in this way, following a rigorous selection process.

The financing offered by CAAP INNOV'ECO is a real boost for the launch and growth of innovative companies. With no collateral required, up to €30,000 over 60 months (with a 12-month grace period) at 0% interest, this loan enables entrepreneurs to launch their projects under the best possible conditions.

Eligibility requirements: To benefit from this financial support, you must be supported by a partner of the Endowment Fund, including Eurobiomed, and be a young start-up presenting a breakthrough innovation with a significant impact on the Caisse Régionale territory.

Project leaders must create their own company and have a KBIS, then pitch their project to the Endowment Fund's Board of Directors for approval.

More information on the Capital & Innovation cluster website